Delivery Order SPE2DB22D3004-SPE2DB24FRE58

Award Date 7/26/24
Potential Completion Date 7/29/24
Potential Value $1.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,197.90, is for the supply of a specific pharmaceutical product, the BREYNA 160-4.5 MCG INHALER 10.3GM. This order is part of a larger Indefinite Delivery Contract (IDC) worth $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a prime vehicle for...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of the drug product BREYNA 160-4.5 MCG INHALER 10.3GM. The contract has a ceiling value of $1,203.46 and a completion date of July 1, 2025. The award is not set-aside and was competed openly. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,163.97, is for the delivery of BREYNA 160-4.5 MCG INHALER 10.3GM, a medical product, to support military healthcare programs. The contract has an ultimate completion date of December 30, 2024 and is a firm fixed-price delivery order. There is no set-aside...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of a specific medication, BREYNA 160-4.5 MCG INHALER 10.3GM, with a ceiling value of $1,671.62. The contract is a firm fixed-price delivery order, without any set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,694.03, is for the procurement of BREYNA 160-4.5 MCG INHALER 10.3GM, a medical product. The contract has an ultimate completion date of January 16, 2025 and is a firm fixed-price delivery order. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a larger...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of the BREYNA 160-4.5 MCG INHALER 10.3GM medical product. The contract has a ceiling value of $13,455.72 and a completion date of June 17, 2024. It is a delivery order contract with a firm-fixed price pricing type. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of the BREYNA 160-4.5 MCG INHALER 10.3GM medical product. The contract has a ceiling value of $45,304.83 and a period of performance through September 5, 2024. It is a firm fixed-price contract with no set-aside designation. Amerisourcebergen has been awarded numerous federal contracts and indefinite delivery contracts (IDCs) by the...
This federal contract award, valued at $1,770.48, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of BREYNA 160-4.5 MCG INHALER 10.3GM, a pharmaceutical product, with an ultimate completion date of November 15, 2024. The contract is a delivery order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of BREYNA 160-4.5 MCG INHALER 10.3GM, a pharmaceutical product. The contract is a firm fixed-price delivery order with a ceiling value of $1,219.08 and a period of performance through June 30, 2025. This order is not set aside and is part of a larger $999,999,999.00 Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of BREYNA 160-4.5 MCG INHALER 10.3GM, a pharmaceutical product. The contract has a firm fixed price pricing type, a ceiling value of $3,147.18, and an ultimate completion date of May 22, 2025. This award is not associated with a set-aside program. Amerisourcebergen Drug Corp holds a...
  • SPE2DB22D3004
    Indefinite Delivery Contract
  • SPE2DB22D3004-SPE2DB24FRE58
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of a pharmaceutical product, the BREYNA 160-4.5 MCG INHALER 10.3GM. The contract has a ceiling value of $1,501.00 and is a firm fixed-price delivery order contract, with a period of performance through July 29, 2024. AmerisourceBergen, a major pharmaceutical distributor, will provide this specialized medical product to support the healthcare needs of the U.S. federal government, particularly military treatment facilities and veterans' hospitals. This contract award is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 that AmerisourceBergen holds with DLA Troop Support Medical for delivering a comprehensive range of medical commodities. There is no set-aside designation for this specific award.

Generated 10/25/24, 9:22 AM